封面
市場調查報告書
商品編碼
2149245

細胞增殖市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。

Cell Expansion Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034

出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

細胞增殖市場的成長要素

全球細胞增殖市場預計到2025年將達到221.4億美元,並從2026年的248.2億美元成長至2034年的540.4億美元,預測期內複合年成長率(CAGR)為10.22%。截至2025年,北美將佔全球細胞增殖市場51.81%的佔有率,成為推動其成長的主要動力。細胞和基因治療、再生醫學、組織工程、藥物研發和生物製藥製造等領域的進步是推動該市場擴張的主要因素。

細胞增殖是指在實驗室條件下對活細胞進行可控制的生長和增殖,用於治療、研發和工業應用。對先進細胞療法的投資增加以及自動化細胞培養技術的開發正在推動市場成長。 2025年6月,Celltrio獲得500萬美元投資,用於推進細胞培養和細胞/基因治療應用的自動化解決方案。賽默飛世爾科技、丹納赫公司和賽多利斯公司等企業正透過產品開發和策略舉措來強化其業務組合。

細胞增殖市場的關鍵點

市場規模及預測:預計2025年市場規模為221.4億美元,2026年達248.2億美元,2034年達540.4億美元。 2026年至2034年,市場預計將以10.22%的複合年成長率成長。

市佔率:預計到 2025 年,北美將佔 51.81% 的市佔率。自動化和封閉式系統預計將以 13.63% 的複合年成長率成長,而免疫細胞預計將以 13.71% 的複合年成長率成長。

主要區域趨勢:預計北美地區到 2025 年將達到 114.7 億美元,歐洲地區到 2026 年將達到 64 億美元,亞太地區到 2025 年將達到 35.2 億美元。

市場動態

市場促進因素:慢性病盛行率上升以及細胞和基因療法的廣泛應用。

癌症、心血管疾病和遺傳性疾病的日益普及推動了對創新細胞療法的需求。細胞增殖是產生足夠數量細胞用於治療的關鍵。因此,對細胞和基因療法以及再生醫學的投資增加正在支撐市場成長。

市場限制:GMP級細胞增殖高成本。

符合GMP規範的細胞增殖高成本,仍是主要的阻礙因素。專用設施、先進設備、品管和監管要求都會增加生產成本。這些費用可能會限制小規模生物技術公司和研究機構獲得治療藥物的機會。

市場機會:異體細胞療法的興起

異體細胞療法的進步為可擴展的細胞生產創造了機會。與自體療法不同,異體療法使用供體細胞,從而支持「現成」療法的開發。對異體生產平台投資的增加預計將進一步刺激對細胞增殖技術的需求。

市場挑戰:熟練工人短缺

細胞增殖需要專門的實驗室知識和技術專長。訓練有素的專業人員短缺會使先進系統的操作以及利用細胞進行的研究和生產活動難以進行。

細胞增殖市場趨勢

將人工智慧整合到設備中

將人工智慧 (AI) 整合到細胞增殖設備中正成為一股重要趨勢。 AI 系統能夠改善細胞處理、成像、監測、自動化和流程最佳化。數位技術的日益普及正在推動更精準、更有效率的細胞研究和生產。

細胞增殖市場細分分析

依產品類型

市場細分分為設備和機械、耗材以及軟體和服務。預計到2025年,耗材將成為市場成長的主要驅動力,這主要得益於對培養基、血清、試劑、生長因子、微載體和一次性生物製程材料的持續需求。設備和機械細分市場預計將以8.82%的複合年成長率成長。

透過技術

市場涵蓋貼壁細胞增殖技術、懸浮細胞增殖技術、自動化密封系統等。 2025年,貼壁細胞增殖技術將佔41.9%的市場佔有率,主要得益於幹細胞研究和再生醫學領域的應用。自動化密封系統預計將以13.63%的複合年成長率成長。

細胞類型

該市場涵蓋幹細胞、免疫細胞和分化細胞。預計到2025年,幹細胞將成為市場成長的主要驅動力,佔36.8%的市場佔有率,這主要得益於幹細胞療法的進步。免疫細胞細分市場預計將以13.71%的複合年成長率成長。

用途別

市場細分包括細胞療法和再生醫學、生物製藥生產、藥物發現與開發等領域。預計到2025年,生物製藥生產將佔41.9%的市場。細胞療法和再生醫學領域預計將以12.58%的複合年成長率成長。

最終用戶

預計到2025年,製藥和生技公司將成為市場的主要驅動力,佔45.2%的市場。藥物發現和研究以及細胞療法開發的投資增加,正在支撐市場需求。學術和研究機構預計將以7.51%的複合年成長率成長。

細胞增生市場區域展望

北美洲

北美將繼續保持區域市場的領先地位,到 2025 年將達到 114.7 億美元。在美國,由於先進的研究基礎設施、對細胞療法的投資以及主要市場參與企業的存在,到 2025 年美國市場將達到 109.1 億美元。

歐洲

預計到 2026 年,歐洲的年複合成長率將達到 10.00%,市場規模將達到 64 億美元。 2025 年,英國、德國和法國的市場規模分別為 12.5 億美元、11.6 億美元和 9.1 億美元。

亞太地區

預計到2025年,亞太地區市場規模將達35.2億美元,成為全球第三大區域市場。印度和中國預計到2025年市場規模將分別達到6.2億美元和6.4億美元。由於再生醫學和先進細胞療法的日益普及,日本仍然是一個重要的市場。

拉丁美洲

預計到 2025 年,拉丁美洲的市場規模將達到 8.9 億美元。這一成長是由參與企業的擴張以及人們對細胞和基因療法自動化生產日益成長的興趣所推動的。

中東和非洲

預計中東和非洲市場將保持溫和成長。海灣合作理事會(GCC)市場在醫療和生物技術領域的投資增加下,預計到2025年將達到2.6億美元。

目錄

第1章:引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章:主要考慮因素

  • 摘要:細胞增生技術進展
  • 產業重大發展動態(合併、收購、合作等)
  • 新產品發布

第5章:全球細胞增殖市場分析、洞察與預測(2021-2034年)

  • 市場分析、洞察與預測:按產品類型分類
    • 設備/器材
    • 消耗品
    • 軟體和服務
  • 市場分析、洞察與預測:按技術分類
    • 貼壁細胞增殖技術
    • 懸浮型細胞增殖技術
    • 自動化和封閉式系統
    • 其他
  • 市場分析、洞察與預測:按細胞類型分類
    • 幹細胞
    • 免疫細胞
    • 分化細胞
    • 其他
  • 市場分析、洞察與預測:按應用領域分類
    • 細胞療法和再生醫學
    • 生物製藥生產
    • 藥物發現與開發
    • 其他
  • 市場分析、洞察與預測:按最終用戶分類
    • 製藥和生物技術公司
    • 學術研究機構
    • 細胞治療與再生醫學中心
    • 其他
  • 分析、洞察與預測:按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章:北美細胞增殖市場分析、洞察與預測(2021-2034年)

  • 國家
    • 美國
    • 加拿大

第7章:歐洲細胞增殖市場分析、洞察與預測(2021-2034年)

  • 國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章:亞太地區細胞增殖市場分析、洞察與預測(2021-2034年)

  • 國家
    • 中國
    • 日本
    • 印度
    • 東南亞
    • 澳洲
    • 其他亞太國家

第9章:拉丁美洲細胞增殖市場分析、洞察與預測(2021-2034年)

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章:中東和非洲細胞增殖市場分析、洞察與預測(2021-2034年)

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析(2025 年)
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Sartorius AG
    • Merck KGaA
    • Lonza Group
    • Corning Incorporated
    • BD
    • Terumo Corporation
    • Miltenyi Biotec
    • Eppendorf SE
Product Code: FBI114949

Growth Factors of cell expansion Market

The global cell expansion market size was valued at USD 22.14 billion in 2025 and is projected to grow from USD 24.82 billion in 2026 to USD 54.04 billion by 2034, exhibiting a CAGR of 10.22% during the forecast period. North America dominated the global cell expansion market with a 51.81% market share in 2025. The market is expanding due to the increasing development of cell and gene therapies, regenerative medicine, tissue engineering, drug discovery, and biopharmaceutical manufacturing.

Cell expansion involves the controlled growth and multiplication of living cells under laboratory conditions for therapeutic, research, and industrial applications. Increasing investments in advanced cell-based therapies and the development of automated cell culture technologies are supporting market growth. In June 2025, Celltrio secured USD 5.0 million in investment to advance automation solutions for cell culturing and cell and gene therapy applications. Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius AG, and other companies are strengthening their portfolios through product development and strategic initiatives.

CELL EXPANSION MARKET KEY TAKEAWAYS

Market Size & Forecast: The market was valued at USD 22.14 billion in 2025, is projected to reach USD 24.82 billion in 2026, and is expected to reach USD 54.04 billion by 2034. The market is expected to grow at a 10.22% CAGR from 2026-2034.

Market Share: North America accounted for 51.81% in 2025. Automated and closed systems are expected to grow at a 13.63% CAGR, while immune cells are projected to grow at a 13.71% CAGR.

Key Regional Highlights: North America reached USD 11.47 billion in 2025, while Europe is projected to reach USD 6.40 billion in 2026. Asia Pacific reached USD 3.52 billion in 2025.

MARKET DYNAMICS

MARKET DRIVERS: Rising Prevalence of Chronic Diseases and Growing Adoption of Cell & Gene Therapies

The rising prevalence of cancer, cardiovascular disorders, and genetic diseases is increasing demand for innovative cell-based treatments. Cell expansion is essential for producing sufficient quantities of cells for therapeutic applications. Growing investments in cell and gene therapies and regenerative medicine are therefore supporting market expansion.

MARKET RESTRAINTS: High Cost of GMP-Grade Cell Expansion

The high cost of GMP-grade cell expansion remains a major restraint. Specialized facilities, advanced equipment, quality controls, and regulatory requirements increase production costs. These expenses can limit accessibility for smaller biotechnology companies and research organizations.

MARKET OPPORTUNITIES: Emergence of Allogenic Cell Therapies

The growing development of allogenic cell therapies is creating opportunities for scalable cell manufacturing. Unlike autologous approaches, allogenic therapies use donor cells and can support the development of off-the-shelf treatments. Increasing investment in allogenic manufacturing platforms is expected to create further demand for cell expansion technologies.

MARKET CHALLENGES: Limited Availability of Skilled Personnel

Cell expansion requires specialized laboratory knowledge and technical expertise. A shortage of trained professionals can create difficulties in operating advanced systems and scaling cell-based research and manufacturing activities.

CELL EXPANSION MARKET TRENDS

Integration of AI in Instruments

The integration of artificial intelligence into cell expansion instruments is emerging as an important trend. AI-enabled systems can improve cell handling, imaging, monitoring, automation, and process optimization. Increasing adoption of digital technologies is supporting more accurate and efficient cell research and manufacturing.

CELL EXPANSION MARKET SEGMENTATION ANALYSIS

By Product Type

The market is segmented into instruments and equipment, consumables, and software and services. Consumables dominated the market in 2025, supported by recurring demand for media, sera, reagents, growth factors, microcarriers, and single-use bioprocessing materials. The instruments and equipment segment is expected to grow at a 8.82% CAGR.

By Technology

The market includes adherent cell expansion technologies, suspension cell expansion technologies, automated and closed systems, and others. Adherent cell expansion technologies held a 41.9% share in 2025, supported by applications in stem cell research and regenerative medicine. Automated and closed systems are expected to grow at a 13.63% CAGR.

By Cell Type

The market includes stem cells, immune cells, differentiated cells, and others. Stem cells dominated with a 36.8% share in 2025, driven by increasing development of stem cell-based therapies. The immune cells segment is expected to grow at a 13.71% CAGR.

By Application

The market is segmented into cell therapy and regenerative medicine, biopharmaceutical production, drug discovery and development, and others. Biopharmaceutical production held a 41.9% share in 2025. The cell therapy and regenerative medicine segment is projected to grow at a 12.58% CAGR.

By End User

Pharmaceutical and biotechnology companies dominated the market with a 45.2% share in 2025. Increasing drug discovery, research investments, and cell-based therapy development are supporting demand. Academic and research institutes are expected to grow at a 7.51% CAGR.

CELL EXPANSION MARKET REGIONAL OUTLOOK

NORTH AMERICA

North America remained the leading regional market, reaching USD 11.47 billion in 2025. The U.S. market reached USD 10.91 billion in 2025, supported by advanced research infrastructure, cell therapy investments, and the presence of major market participants.

EUROPE

Europe is projected to record a 10.00% CAGR and reach USD 6.40 billion in 2026. The U.K., Germany, and France recorded USD 1.25 billion, USD 1.16 billion, and USD 0.91 billion, respectively, in 2025.

ASIA PACIFIC

Asia Pacific reached USD 3.52 billion in 2025, making it the third-largest regional market. India and China recorded USD 0.62 billion and USD 0.64 billion, respectively, in 2025. Japan remains an important market due to increasing adoption of regenerative medicine and advanced cell-based therapies.

LATIN AMERICA

Latin America recorded USD 0.89 billion in 2025. Increasing expansion by market participants and growing interest in automated cell and gene therapy manufacturing are supporting regional development.

MIDDLE EAST & AFRICA

The Middle East & Africa market is expected to experience moderate growth. The GCC market reached USD 0.26 billion in 2025, supported by increasing healthcare and biotechnology investments.

COMPETITIVE LANDSCAPE

Key Industry Players: Expansion of Product Offerings and Research Activities

The global cell expansion market is fragmented, with numerous companies operating across different product and technology categories. Major companies include Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius AG, Merck KGaA, Lonza Group, Corning Incorporated, BD, Terumo Corporation, Miltenyi Biotec, and Eppendorf SE.

KEY INDUSTRY DEVELOPMENTS

September 2025: Sartorius AG expanded its manufacturing facility in Illkirch, France, supporting the production of transfection reagents for cell and gene therapies.

August 2025: Danaher Corporation's Cytiva collaborated with Culture Biosciences to integrate cloud-connected bioreactor technology for digital bioprocessing.

March 2025: Cytiva expanded the Xcellerex X-platform portfolio with 500-L and 2,000-L bioreactors for advanced therapeutic manufacturing.

October 2024: Terumo Corporation expanded its presence in Latin America to support automated manufacturing solutions for cell and gene therapy companies.

October 2023: Terumo Corporation and BioCentriq collaborated on automated cell and gene therapy platforms for CAR-T cell development.

REPORT COVERAGE

The global cell expansion market report covers market size and forecast for 2025, 2026, and 2034, along with segmentation by product type, technology, cell type, application, end user, and geography. The report includes market dynamics, trends, opportunities, challenges, technological advancements, product launches, strategic collaborations, and competitive developments.

CONCLUSION

The global cell expansion market is projected to increase from USD 22.14 billion in 2025 to USD 24.82 billion in 2026 and reach USD 54.04 billion by 2034. Rising adoption of cell and gene therapies, increasing demand for regenerative medicine, expansion of biopharmaceutical manufacturing, and development of automated and closed cell expansion systems are supporting market growth. North America remains the leading regional market, while Europe and Asia Pacific are expanding through investments in cell-based research, advanced therapies, and biomanufacturing technologies.

Segmentation By Product Type, Technology, Cell Type, Application, End User, and Region

By Product Type

  • Instruments & Equipment
  • Consumables
  • Software & Services

By Technology

  • Adherent Cell Expansion Technologies
  • Suspension Cell Expansion Technologies
  • Automated & Closed Systems
  • Others

By Cell Type

  • Stem Cells
  • Immune Cells
  • Differentiated Cells
  • Others

By Application

  • Cell Therapy & Regenerative Medicine
  • Biopharmaceutical Production
  • Drug Discovery & Development
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Cell Therapy & Regenerative Medicine Centers
  • Others

By Geography

  • North America (By Product Type, Technology, Cell Type, Application, End User, and Country)
    • U.S.
    • Canada
  • Europe (By Product Type, Technology, Cell Type, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, Technology, Cell Type, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, Technology, Cell Type, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, Technology, Cell Type, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview: Technological Advancements In Cell Expansion
  • 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, among others.)
  • 4.3. New Product Launches

5. Global Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Instruments & Equipment
    • 5.1.2. Consumables
    • 5.1.3. Software & Services
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Adherent Cell Expansion Technologies
    • 5.2.2. Suspension Cell Expansion Technologies
    • 5.2.3. Automated & Closed Systems
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Cell Type
    • 5.3.1. Stem Cells
    • 5.3.2. Immune Cells
    • 5.3.3. Differentiated Cells
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Cell Therapy & Regenerative Medicine
    • 5.4.2. Biopharmaceutical Production
    • 5.4.3. Drug Discovery & Development
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End User
    • 5.5.1. Pharmaceutical & Biotechnology Companies
    • 5.5.2. Academic & Research Institutes
    • 5.5.3. Cell Therapy & Regenerative Medicine Centers
    • 5.5.4. Others
  • 5.6. Market Analysis, Insights and Forecast - Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Instruments & Equipment
    • 6.1.2. Consumables
    • 6.1.3. Software & Services
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Adherent Cell Expansion Technologies
    • 6.2.2. Suspension Cell Expansion Technologies
    • 6.2.3. Automated & Closed Systems
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Cell Type
    • 6.3.1. Stem Cells
    • 6.3.2. Immune Cells
    • 6.3.3. Differentiated Cells
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Cell Therapy & Regenerative Medicine
    • 6.4.2. Biopharmaceutical Production
    • 6.4.3. Drug Discovery & Development
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End User
    • 6.5.1. Pharmaceutical & Biotechnology Companies
    • 6.5.2. Academic & Research Institutes
    • 6.5.3. Cell Therapy & Regenerative Medicine Centers
    • 6.5.4. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Instruments & Equipment
    • 7.1.2. Consumables
    • 7.1.3. Software & Services
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Adherent Cell Expansion Technologies
    • 7.2.2. Suspension Cell Expansion Technologies
    • 7.2.3. Automated & Closed Systems
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Cell Type
    • 7.3.1. Stem Cells
    • 7.3.2. Immune Cells
    • 7.3.3. Differentiated Cells
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Cell Therapy & Regenerative Medicine
    • 7.4.2. Biopharmaceutical Production
    • 7.4.3. Drug Discovery & Development
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End User
    • 7.5.1. Pharmaceutical & Biotechnology Companies
    • 7.5.2. Academic & Research Institutes
    • 7.5.3. Cell Therapy & Regenerative Medicine Centers
    • 7.5.4. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Instruments & Equipment
    • 8.1.2. Consumables
    • 8.1.3. Software & Services
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Adherent Cell Expansion Technologies
    • 8.2.2. Suspension Cell Expansion Technologies
    • 8.2.3. Automated & Closed Systems
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Cell Type
    • 8.3.1. Stem Cells
    • 8.3.2. Immune Cells
    • 8.3.3. Differentiated Cells
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Cell Therapy & Regenerative Medicine
    • 8.4.2. Biopharmaceutical Production
    • 8.4.3. Drug Discovery & Development
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End User
    • 8.5.1. Pharmaceutical & Biotechnology Companies
    • 8.5.2. Academic & Research Institutes
    • 8.5.3. Cell Therapy & Regenerative Medicine Centers
    • 8.5.4. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.6.1. China
    • 8.6.2. Japan
    • 8.6.3. India
    • 8.6.4. Southeast Asia
    • 8.6.5. Australia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Instruments & Equipment
    • 9.1.2. Consumables
    • 9.1.3. Software & Services
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Adherent Cell Expansion Technologies
    • 9.2.2. Suspension Cell Expansion Technologies
    • 9.2.3. Automated & Closed Systems
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Cell Type
    • 9.3.1. Stem Cells
    • 9.3.2. Immune Cells
    • 9.3.3. Differentiated Cells
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Cell Therapy & Regenerative Medicine
    • 9.4.2. Biopharmaceutical Production
    • 9.4.3. Drug Discovery & Development
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End User
    • 9.5.1. Pharmaceutical & Biotechnology Companies
    • 9.5.2. Academic & Research Institutes
    • 9.5.3. Cell Therapy & Regenerative Medicine Centers
    • 9.5.4. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Instruments & Equipment
    • 10.1.2. Consumables
    • 10.1.3. Software & Services
  • 10.2. Market Analysis, Insights and Forecast - By Technology
    • 10.2.1. Adherent Cell Expansion Technologies
    • 10.2.2. Suspension Cell Expansion Technologies
    • 10.2.3. Automated & Closed Systems
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Cell Type
    • 10.3.1. Stem Cells
    • 10.3.2. Immune Cells
    • 10.3.3. Differentiated Cells
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Cell Therapy & Regenerative Medicine
    • 10.4.2. Biopharmaceutical Production
    • 10.4.3. Drug Discovery & Development
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End User
    • 10.5.1. Pharmaceutical & Biotechnology Companies
    • 10.5.2. Academic & Research Institutes
    • 10.5.3. Cell Therapy & Regenerative Medicine Centers
  • 10.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of the Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Danaher Corporation
    • 11.2.3. Sartorius AG
    • 11.2.4. Merck KGaA
    • 11.2.5. Lonza Group
    • 11.2.6. Corning Incorporated
    • 11.2.7. BD
    • 11.2.8. Terumo Corporation
    • 11.2.9. Miltenyi Biotec
    • 11.2.10. Eppendorf SE

List of Tables

  • Table 1: Global Cell Expansion Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 2: Global Cell Expansion Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 3: Global Cell Expansion Market Revenue (USD billion) Forecast, by Type 2021-2034
  • Table 4: Global Cell Expansion Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Cell Expansion Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 6: Global Cell Expansion Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Cell Expansion Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 8: North America Cell Expansion Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 9: North America Cell Expansion Market Revenue (USD billion) Forecast, by Type 2021-2034
  • Table 10: North America Cell Expansion Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Cell Expansion Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 12: North America Cell Expansion Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 13: Europe Cell Expansion Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 14: Europe Cell Expansion Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 15: Europe Cell Expansion Market Revenue (USD billion) Forecast, by Type 2021-2034
  • Table 16: Europe Cell Expansion Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Cell Expansion Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 18: Europe Cell Expansion Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Cell Expansion Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 20: Asia Pacific Cell Expansion Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 21: Asia Pacific Cell Expansion Market Revenue (USD billion) Forecast, by Type 2021-2034
  • Table 22: Asia Pacific Cell Expansion Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Cell Expansion Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 24: Asia Pacific Cell Expansion Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 25: Latin America Cell Expansion Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 26: Latin America Cell Expansion Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 27: Latin America Cell Expansion Market Revenue (USD billion) Forecast, by Type 2021-2034
  • Table 28: Latin America Cell Expansion Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29: Latin America Cell Expansion Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 30: Latin America Cell Expansion Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Cell Expansion Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 32: Middle East & Africa Cell Expansion Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 33: Middle East & Africa Cell Expansion Market Revenue (USD billion) Forecast, by Type 2021-2034
  • Table 34: Middle East & Africa Cell Expansion Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Cell Expansion Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 36: Middle East & Africa Cell Expansion Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Cell Expansion Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Cell Expansion Market Value Share (%), By Product Type, 2025 & 2034
  • Figure 3: Global Cell Expansion Market Value Share (%), By Technology, 2025 & 2034
  • Figure 4: Global Cell Expansion Market Value Share (%), By Cell Type, 2025 & 2034
  • Figure 5: Global Cell Expansion Market Value Share (%), by Application, 2025 & 2034
  • Figure 6: Global Cell Expansion Market Value Share (%), By End User, 2025 & 2034
  • Figure 7: Global Cell Expansion Market Value Share (%), by Region, 2025 & 2034
  • Figure 8: North America Cell Expansion Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 9: North America Cell Expansion Market Value Share (%), By Product Type, 2025
  • Figure 10: North America Cell Expansion Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 11: North America Cell Expansion Market Value Share (%), By Technology, 2025
  • Figure 12: North America Cell Expansion Market Value (USD billion), By Cell Type 2025 & 2034
  • Figure 13: North America Cell Expansion Market Value Share (%), By Cell Type 2024
  • Figure 14: North America Cell Expansion Market Value (USD billion), by Application, 2025 & 2034
  • Figure 15: North America Cell Expansion Market Value Share (%), by Application, 2025
  • Figure 16: North America Cell Expansion Market Value (USD billion), By End User, 2025 & 2034
  • Figure 17: North America Cell Expansion Market Value Share (%), By End User, 2025
  • Figure 18: North America Cell Expansion Market Value (USD billion), by Country, 2025 & 2034
  • Figure 19: North America Cell Expansion Market Value Share (%), by Country, 2025
  • Figure 20: Europe Cell Expansion Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 21: Europe Cell Expansion Market Value Share (%), By Product Type, 2025
  • Figure 22: Europe Cell Expansion Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 23: Europe Cell Expansion Market Value Share (%), By Technology, 2025
  • Figure 24: Europe Cell Expansion Market Value (USD billion), By Cell Type 2025 & 2034
  • Figure 25: Europe Cell Expansion Market Value Share (%), By Cell Type 2024
  • Figure 26: Europe Cell Expansion Market Value (USD billion), by Application, 2025 & 2034
  • Figure 27: Europe Cell Expansion Market Value Share (%), by Application, 2025
  • Figure 28: Europe Cell Expansion Market Value (USD billion), By End User, 2025 & 2034
  • Figure 29: Europe Cell Expansion Market Value Share (%), By End User, 2025
  • Figure 30: Europe Cell Expansion Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe Cell Expansion Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 32: Asia Pacific Cell Expansion Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 33: Asia Pacific Cell Expansion Market Value Share (%), By Product Type, 2025
  • Figure 34: Asia Pacific Cell Expansion Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 35: Asia Pacific Cell Expansion Market Value Share (%), By Technology, 2025
  • Figure 36: Asia Pacific Cell Expansion Market Value (USD billion), By Cell Type 2025 & 2034
  • Figure 37: Asia Pacific Cell Expansion Market Value Share (%), By Cell Type 2024
  • Figure 38: Asia Pacific Cell Expansion Market Value (USD billion), by Application, 2025 & 2034
  • Figure 39: Asia Pacific Cell Expansion Market Value Share (%), by Application, 2024
  • Figure 40: Asia Pacific Cell Expansion Market Value (USD billion), By End User, 2025 & 2034
  • Figure 41: Asia Pacific Cell Expansion Market Value Share (%), By End User, 2025
  • Figure 42: Asia Pacific Cell Expansion Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Cell Expansion Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 44: Latin America Cell Expansion Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 45: Latin America Cell Expansion Market Value Share (%), By Product Type, 2025
  • Figure 46: Latin America Cell Expansion Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 47: Latin America Cell Expansion Market Value Share (%), By Technology, 2025
  • Figure 48: Latin America Cell Expansion Market Value (USD billion), By Cell Type 2025 & 2034
  • Figure 49: Latin America Cell Expansion Market Value Share (%), By Cell Type 2024
  • Figure 50: Latin America Cell Expansion Market Value (USD billion), by Application, 2025 & 2034
  • Figure 51: Latin America Cell Expansion Market Value Share (%), by Application, 2025
  • Figure 52: Latin America Cell Expansion Market Value (USD billion), By End User, 2025 & 2034
  • Figure 53: Latin America Cell Expansion Market Value Share (%), By End User, 2025
  • Figure 54: Latin America Cell Expansion Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America Cell Expansion Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa Cell Expansion Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 57: Middle East & Africa Cell Expansion Market Value Share (%), By Product Type, 2025
  • Figure 58: Middle East & Africa Cell Expansion Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 59: Middle East & Africa Cell Expansion Market Value Share (%), By Technology, 2025
  • Figure 60: Middle East & Africa Cell Expansion Market Value (USD billion), By Cell Type 2025 & 2034
  • Figure 61: Middle East & Africa Cell Expansion Market Value Share (%), By Cell Type 2024
  • Figure 62: Middle East & Africa Cell Expansion Market Value (USD billion), by Application, 2025 & 2034
  • Figure 63: Middle East & Africa Cell Expansion Market Value Share (%), by Application, 2025
  • Figure 64: Middle East & Africa Cell Expansion Market Value (USD billion), By End User, 2025 & 2034
  • Figure 65: Middle East & Africa Cell Expansion Market Value Share (%), By End User, 2025
  • Figure 66: Middle East & Africa Cell Expansion Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Cell Expansion Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 68: Global Cell Expansion MarketShare (%), by Company, 2025